Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK6 | Q16659 | 10/20 | 0.44 |
| ▸ | MAPK8 | P45983 | 7/20 | 0.39 |
| ▸ | MAPK9 | P45984 | 4/20 | 0.39 |
| ▸ | HPGDS | O60760 | 1/20 | 0.37 |
| ▸ | AXL | P30530 | 1/20 | 0.36 |
| ▸ | FLT3 | P36888 | 1/20 | 0.36 |
| ▸ | TYRO3 | Q06418 | 1/20 | 0.36 |
| ▸ | MERTK | Q12866 | 1/20 | 0.36 |
| ▸ | GAS6 | Q14393 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18830031 | 0.94 | MAPK6 (0.42) | MAPK6MAPK8MAPK9HPGDSAXL | |
| SCHEMBL18830273 | 0.93 | MAPK6 (0.40) | MAPK6MAPK8MAPK9HPGDS | |
| SCHEMBL18830135 | 0.87 | MAPK6 (0.47) | MAPK6 | |
| SCHEMBL18830394 | 0.87 | MAPK6 (0.43) | MAPK6MERTK | |
| SCHEMBL18830422 | 0.87 | MAPK6 (0.41) | MAPK6MAPK8AXLFLT3TYRO3 | |
| SCHEMBL18830434 | 0.86 | MAPK6 (0.52) | MAPK6MAPK8AXLTYRO3MERTK | |
| SCHEMBL18830090 | 0.86 | SYK (0.44) | MAPK6MERTK | |
| SCHEMBL18830136 | 0.86 | SYK (0.42) | MAPK6MERTK | |
| SCHEMBL18830167 | 0.85 | MAPK6 (0.42) | MAPK6 | |
| SCHEMBL18830257 | 0.85 | MEN1 (0.43) | MAPK6MERTK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2964649-B1 | TRIAZOLO[4,5-D]PYRIMIDINE DERIVATIVES FOR THE TREATMENT OF DISEASES SUCH AS CANCER | MERCK PATENT GMBH (DE) | 2017-05-10 | — | — | EP | disclosed |